Filing metadata

Accession number
0001606074-19-000019
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Jul 31, 2019
Reporting period
Jul 29, 2019
Description
Insider transaction

Explore SEC Filings Hub